Implementation Guide CH VACD
4.0.1 - trial-use
This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Official URL: http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs | Version: 4.0.1 | |||
Active as of 2023-12-28 | Computable Name: SwissVaccinationPlanImmunizations | |||
Other Identifiers: id: 2.16.756.5.30.1.1.11.71 (use: OFFICIAL) | ||||
Copyright/Legal: CC0-1.0 |
Immunization procedures for recommendations according to the vaccination plan.
References
http://snomed.info/sct
Code | Display |
42284007 | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) |
76668005 | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) |
127787002 | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) |
243789007 | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) |
16584000 | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) |
86198006 | Administration of vaccine product containing only Influenza virus antigen (procedure) |
314759000 | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) |
47435007 | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) |
719596001 | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
871874000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) |
50583002 | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) |
761841000 | Administration of vaccine product containing only Human papillomavirus antigen (procedure) |
39343008 | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) |
1119368005 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) |
1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) |
1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) |
72093006 | Administration of vaccine product containing only Human poliovirus antigen (procedure) |
34631000 | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) |
82314000 | Administration of vaccine product containing only Rubella virus antigen (procedure) |
127786006 | Administration of vaccine product containing only Clostridium tetani antigen (procedure) |
281658005 | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) |
15483003 | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) |
737081007 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) |
722215002 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) |
67308009 | Administration of vaccine product containing only Yellow fever virus antigen (procedure) |
1157107003 | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) |
1119350007 | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) |
1209198003 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) |
1162645008 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) |
Additional Language Displays
Code | Deutsch (Schweiz) (German (Switzerland), de) | English (United States) (English (United States), en) | French (Switzerland) (fr) | Italian (Switzerland) (it) | rm |
42284007 | BCG-Impfung | BCG vaccination | vaccination par le BCG | vaccinazione contro la tubercolosi | vaccinaziun cunter tuberculosa |
76668005 | Diphterie-Impfung | Diphtheria vaccination | vaccination contre la diphtérie | vaccinazione contro la difterite | vaccinaziun cunter difteria |
127787002 | Impfung gegen Haemophilus influenzae Typ B | Haemophilus influenzae type b vaccination | vaccination contre l'Haemophilus influenzae de type B | vaccinazione contro l'Haemophilus influenzae di tipo b | vaccinaziun cunter hemofilus influenza tip B |
243789007 | Hepatitis-A-Impfung | Hepatitis A vaccination | vaccination contre l'hépatite A | vaccinazione contro l'epatite A | vaccinaziun cunter hepatitis A |
16584000 | Hepatitis-B-Impfung | Hepatitis B vaccination | vaccination contre l'hépatite B | vaccinazione contro l'epatite B | vaccinaziun cunter hepatitis B |
86198006 | Grippeimpfung | Influenza vaccination | vaccination contre l'influenza | vaccinazione contro l'influenza | vaccinaziun cunter la grippa |
314759000 | Impfung gegen Japanische Enzephalitis | Japanese encephalitis vaccination | vaccination contre l'encéphalite japonaise | Jvaccinazione contro l'encefalite giapponese | vaccinaziun cunter l'encefalitis giapunaisa |
47435007 | Masernimpfung | Measles vaccination | vaccination antirougeoleuse | vaccinazione contro il morbillo | vaccinaziun cunter il virustgel |
719596001 | Meningitis-C-Impfung | Meningitis C vaccination | vaccination contre la méningite C | vaccinazione contro la meningite C | vaccinaziun cunter meninghitis C |
314417000 | Meningitis-A-und-C-Impfung | Meningitis A and C vaccination | vaccination contre les méningites A et C | vaccinazione contro la meningite A e C | vaccinaziun cunter meninghitis A e C |
871874000 | Meningitis-A, C-, W135- und Y-Impfung | Meningitis A, C, W135 and Y vaccination | vaccination contre les méningites A, C, W135 et Y | vaccinazione contro la meningite A, C, W135 e Y | vaccinaziun cunter meninghitis A, C, W135 ed Y |
50583002 | Mumpsimpfung | Mumps vaccination | vaccination contre les oreillons | vaccinazione contro la parotite | vaccinaziun cunter il glandun |
761841000 | Impfung gegen humane Papillomaviren | Human papillomavirus vaccination | vaccination contre le papillomavirus humain | vaccinazione contro il virus del papilloma umano | vaccinaziun cunter ils papillomavirus umans |
39343008 | Pertussis-Impfung | Pertussis vaccination | vaccination contre la coqueluche | vaccinazione contro la pertosse | vaccinaziun cunter la tuss chanina |
1119368005 | 7-valente Pneumokokken-Konjugatimpfung | Pneumococcal 7-valent conjugate vaccination | vaccination antipneumococcique conjugué 7-valent | vaccinazione con vaccino coniugato eptavalente contro gli pneumococchi | vaccinaziun cunter pneumococcus cun vaccin fusiunà valenza 7 |
1119366009 | 13-valente Pneumokokken-Konjugatimpfung | Pneumococcal 13-valent conjugate vaccination | vaccination antipneumococcique conjugué 13-valent | vaccinazione con vaccino coniugato 13-valente contro gli pneumococchi | vaccinaziun cunter pneumococcus cun vaccin fusiunà valenza 13 |
1119367000 | 23-valente Pneumokokken-Konjugatimpfung | Pneumococcal 23-valent conjugate vaccination | vaccination antipneumococcique conjugué 23- valent | vaccinazione con vaccino coniugato 23-valente contro gli pneumococchi | vaccinaziun cunter pneumococcus cun vaccin fusiunà valenza 23 |
72093006 | Polio-Impfung | Poliomyelitis vaccination | vaccination contre la poliomyélite | vaccinazione contro la poliomielite | vaccinaziun cunter poliomielitica |
34631000 | Tollwut-Impfung | Rabies vaccination | vaccination contre la rage | vaccinazione contro la rabbia | vaccinaziun cunter la frenesia |
82314000 | Röteln-Impfung | Rubella vaccination | vaccination contre la rubéole | vaccinazione contro la rosolia | vaccinaziun cunter la rubella |
127786006 | Tetanus-Impfung | Tetanus vaccination | vaccination contre le tétanos | vaccinazione contro il tetano | vaccinaziun cunter tetanus |
281658005 | FSME-Impfung | Tick-borne encephalitis vaccination | vaccination contre l'encéphalite à tiques | vaccinazione contro la meningoencefalite da zecche | vaccinaziun cunter la meningoencefalitis da zeccas |
15483003 | Typhus-Impfung | Typhoid vaccination | vaccination antityphoïdique | vaccinazione contro la febbre tifoidea | vaccinaziun cunter tifus |
737081007 | Varizellen-Zoster-Impfung gegen Windpocken | Varicella-zoster vaccination for chickenpox | vaccination varicelle-zona contre la varicelle | vaccinazione contro il virus varicella-zoster: solo varicella | vaccinaziun cunter la virola selvadia |
722215002 | Varizellen-Zoster-Impfung gegen Gürtelrose | Varicella-zoster vaccination for shingles | vaccination varicelle-zona contre le zona | vaccinazione contro il virus varicella-zoster: solo herpes zoster | vaccinaziun cunter herpes zoster |
67308009 | Gelbfieber-Impfung | Yellow fever vaccination | vaccination contre la fièvre jaune | vaccinazione contro la febbre gialla | vaccinaziun cunter la fevra melna |
1157107003 | Nicht replizierende virale Vektorimpfung gegen COVID-19 | COVID-19 non-replicating viral vector vaccination | administration d'un vaccin à vecteur viral recombinant non réplicatif contre le COVID-19 | vaccinazione con vaccino a vettore virale non replicante anti-COVID-19 | vaccinaziun cunter COVID-19 cun vaccin vectorial viral betg replitgant |
1119350007 | mRNA-Impfung gegen COVID-19 | COVID-19 mRNA vaccination | administration d'un vaccin à ARNm du SARS-CoV-2 | vaccinazione con vaccino a mRNA anti-COVID-19 | vaccinaziun cunter COVID-19 cun vaccin mRNA |
1209198003 | Impfung gegen die humanen Papillomaviren 6, 11, 16, 18, 31, 33, 45, 52 und 58 | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccination | vaccination contre le papillomavirus humain 6, 11, 16, 18, 31, 33, 45, 52 and 58 | vaccinazione contro i papillomavirus umani 6, 11, 16, 18, 31, 33, 45, 52 e 58 | vaccinaziun cunter ils papillomavirus umans 6, 11, 16, 18, 31, 33, 45, 52 e 58 |
1162645008 | Impfung gegen Covid-19 mit rekombinanten Spike-Protein-Antigenen | COVID-19 recombinant spike protein antigen vaccination | vaccination antigénique à protéine Spike recombinante contre le COVID-19 | vaccinazione con vaccino antigenico anti-COVID-19 con proteina spike ricombinante | vaccinaziun cunter COVID-19 cun antigens dal protein spike recumbinant |
Expansion based on:
This value set contains 30 concepts
Code | System | Display |
42284007 | http://snomed.info/sct | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) |
76668005 | http://snomed.info/sct | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) |
127787002 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) |
243789007 | http://snomed.info/sct | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) |
16584000 | http://snomed.info/sct | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) |
86198006 | http://snomed.info/sct | Administration of vaccine product containing only Influenza virus antigen (procedure) |
314759000 | http://snomed.info/sct | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) |
47435007 | http://snomed.info/sct | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) |
719596001 | http://snomed.info/sct | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
314417000 | http://snomed.info/sct | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
871874000 | http://snomed.info/sct | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) |
50583002 | http://snomed.info/sct | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) |
761841000 | http://snomed.info/sct | Administration of vaccine product containing only Human papillomavirus antigen (procedure) |
39343008 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) |
1119368005 | http://snomed.info/sct | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) |
1119366009 | http://snomed.info/sct | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) |
1119367000 | http://snomed.info/sct | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) |
72093006 | http://snomed.info/sct | Administration of vaccine product containing only Human poliovirus antigen (procedure) |
34631000 | http://snomed.info/sct | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) |
82314000 | http://snomed.info/sct | Administration of vaccine product containing only Rubella virus antigen (procedure) |
127786006 | http://snomed.info/sct | Administration of vaccine product containing only Clostridium tetani antigen (procedure) |
281658005 | http://snomed.info/sct | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) |
15483003 | http://snomed.info/sct | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) |
737081007 | http://snomed.info/sct | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) |
722215002 | http://snomed.info/sct | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) |
67308009 | http://snomed.info/sct | Administration of vaccine product containing only Yellow fever virus antigen (procedure) |
1157107003 | http://snomed.info/sct | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) |
1119350007 | http://snomed.info/sct | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) |
1209198003 | http://snomed.info/sct | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) |
1162645008 | http://snomed.info/sct | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |